Application of glycoproteomics for the discovery of biomarkers in lung cancer

Proteomics - Clinical Applications

Volumn 6, Issue 5-6, 2012, Pages 244-256

  Kay Li, Qing ^a   Gabrielson, Edward ^a   Zhang, Hui ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Glycoproteins; Glycoproteomics; Lung cancer; Nonsmall cell lung cancer (NSCLC); Protein biomarkers

Indexed keywords

ADIPONECTIN; ADVANCED GLYCATION END PRODUCT; ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; ALPHA ENOLASE; BORONIC ACID DERIVATIVE; CA 125 ANTIGEN; CALRETICULIN; CARBONATE DEHYDRATASE II; CERULOPLASMIN; CYCLIN H; FETUIN A; FRUCTOSE BISPHOSPHATE ALDOLASE; GLYCEROPHOSPHOINOSITOL INOSITOLPHOSPHODIESTERASE; GLYCOPROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL 80; HEMOGLOBIN BETA CHAIN; LECTIN; LIPOCALIN TYPE PROSTAGLANDIN D SYNTHASE; LIPOCORTIN 1; MITOCHONDRIAL SUPEROXIDE DISMUTASE; PEROXIREDOXIN 2; PROTEIN DISULFIDE ISOMERASE A1; PROTEIN KINASE FYN; PROTEOSOME SUBUNIT BETA TYPE 1; SOMATOMEDIN BINDING PROTEIN; TRANSGELIN; TUMOR MARKER; UNCLASSIFIED DRUG; VIMENTIN;

BORONIC ACID CAPTURE; BREATH ANALYSIS; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER PROGNOSIS; CHEMICAL CAPTURE; CHEMICAL PROCEDURES; CHEMICAL REACTION; DRUG MONITORING; EARLY DIAGNOSIS; EXHALED BREATH CONDENSATE; GLYCOPROTEOMICS; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; LECTIN AFFINITY CAPTURE; LUNG CANCER; LUNG LAVAGE; PLEURA EFFUSION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ENRICHMENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN IMMOBILIZATION; PROTEOMICS; REVIEW; TISSUE SECTION; TREATMENT RESPONSE; TUMOR BIOPSY;

ANIMALS; GLYCOPROTEINS; HUMANS; LUNG NEOPLASMS; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 84863206749     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201100042     Document Type: Review

References (90)

1. Jemal, A., Siegel, R., Xu, J., Ward, E., Cancer statistics, 2010. CA Cancer J. Clin. 2010, 60, 227-300.
2. Travis, W. D., IASLC Staging Committee. Reporting lung cancer pathology specimens. Impact of the anticipated 7th Edition TNM classification based on recommendations of the IASLC Staging Committee. Histopathology 2009, 54, 3-11.
3. Harpole, D. H., Herndon, J. E., Young, W. G., Wolfe, W. G. et al., Stage I non-small cell lung cancer. Cancer 1995, 76, 787-796.
4. Swensen, S. J., Jett, J. R., Hartman, T. E., Mandrekar, S. J. et al., CT screening for lung cancer: five-year prospective experience. Radiology 2005, 235, 259-265.
5. National Lung Screening Trial Research Team, Aberle, D. R., Adams, A. M., Berg, C. D. et al., Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 2011, 365, 395-409. Epub 2011 Jun 29.
6. Mok, T. S., Wu, Y. L., Thongprasent, S., Yang, C. H. et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N. Engl. J. Med. 2009, 361, 947-957.
7. Chen, H. Y., Yu, S. L., Chen, C. H., Chang, G. C. et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N. Engl. J. Med. 2007, 356, 11-20.
8. Coate, L. E., John, T., Tsao, M. S., Shepherd, F. A., Molecular predictive and prognostic markers in non-small-cell lung cancer. Lancet Oncol. 2009, 10, 1001-1010.
9. Klabunde, C. N., Marcus, P. M., Silvestri, G. A., Han, P. K. et al., U.S. primary care physicians' lung cancer screening beliefs and recommendations. Am. J. Prev. Med. 2010, 39, 411-420.
10. Yanagisawa, K., Shyr, Y., Xu, B. J., Massion, P. P. et al., Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 2003, 362, 433-439.
11. Buhrens, R. I., Amelung, J. T., Reymond, M. A., Beshay, M., Protein expression in human non-small cell lung cancer: a systematic database. Pathobiology 2009, 76, 277-285.
12. Lehtio, J., De Petris, L., Lung cancer proteomics, clinical and technological considerations. J. Proteome. 2010, 73, 1851-1863.
13. Vegvari, A., Marko-Varga, G., Clinical protein science and bioanalytical mass spectrometry with an emphasis on lung cancer. Chem. Rev. 2010, 110, 3278-3298.
14. Tian, T., Hao, J., Xu, A., Hao, J. et al., Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis. Cancer Sci. 2007, 98, 1265-1274.
15. Yao, H., Zhang, Z., Xiao, Z., Chen, Y. et al., Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection. Lung Cancer 2009, 65, 41-48.
16. Rahman, S. M., Shyr, Y., Yildiz, P. B., Gonzalez, A. L. et al. Proteomic patterns of preinvasive bronchial lesions. Am. J. Respir. Crit. Care Med. 2005, 172, 1556-1562.
17. Au, J. S., Cho, W. C., Yip, T. T., Law, S. C., Proteomic approach to biomarker discovery in cancer tissue from lung adenocarcinoma among nonsmoking Chinese women in Hong Kong. Cancer Investig. 2008, 26, 128-135.
18. Campa, M. J., Wang, M. Z., Howard, B., Fitzgerald, M. C. et al., Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer. Cancer Res. 2003, 63, 1652-1656.
19. Kawamura, T., Nomura, M., Tojo, H., Fujii, K. et al., Proteomic analysis of laser-microdissected paraffin-embedded tissues: (1) stage-related protein candidates upon non-metastatic lung adenocarcinoma. J. Proteome 2010, 73, 1089-1099.
20. Nishimura, T., Nomura, M., Tojo, H., Hamasaki, H. et al., Proteomic analysis of laser-microdissected paraffin-embedded tissues: (2) MRM assay for stage-related proteins upon non-metastatic lung adenocarcinoma. J. Proteome 2010, 73, 1100-1110.
21. Oshita, F., Morita, A., Ito, H., Kameda, Y. et al., Proteomic screening of completely resected tumors in relation to survival in patients with stage I non-small cell lung cancer. Oncol. Rep. 2010, 24, 637-645.
22. Hirano, T., Kato, H., Present status of clinical proteomic analysis for the early detection and determination of therapeutic strategy in lung cancer. Ann. Thorac. Cardiovasc. Surg. 2006, 12, 4-9.
23. Apweiler, R., Hermjakob, H., Sharon, N., On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta 1999, 1473, 4-8.
24. Wong, C. H., Protein glycosylation: new challenges and opportunities. J. Org. Chem. 2005, 70, 4219-4225.
25. Helenius, A., Aebi, M., Intracellular functions of N-linked glycans. Science 2001, 291, 2364-2369.
26. Isaji, T., Gu, J., Nishiuchi, R., Zhao, Y. et al., Introduction of bisecting GlcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration. J. Biol. Chem. 2004, 279, 19747-19754.
27. Rudd, P. M., Elliott, T., Cresswell, P., Wilson, I. A. et al. Glycosylation and the immune system. Science 2001, 291, 2370-2376.
28. Lowe, J. B., Marth, J. D., A genetic approach to mammalian glycan function. Annu. Rev. Biochem. 2003, 72, 643-691.
29. Drake, P. M., Cho, W., Li, B., Prakobphol, A. et al., Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin. Chem. 2010, 56, 223-236.
30. Tian, Y., Zhang, H., Glycoproteomics and clinical applications. Proteomics Clin. Appl. 2010, 4, 124-132.
31. Kam, R. K. T., Poon, T. C. W., The potentials of glycomics in biomarker discovery. Clin. Proteom. 2008, 4, 67-79.
32. Varki, A., Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993, 3, 97-130.
33. Fares, F., The role of O-linked and N-linked oligosaccharides on the structure-function of glycoprotein hormones: development of agonists and antagonists. Biochim. Biophys. Acta 2006, 1760, 560-567.
34. Tong, L., Baskaran, G., Jones, M. B., Rhee, J. K. et al., Glycosylation changes as markers for the diagnosis and treatment of human disease. Biotechnol. Genet. Eng. Rev. 2003, 20, 199-244.
35. Powlesland, A. S., Hitchen, P. G., Parry, S., Graham, S. A. et al., Targeted glycoproteomic identification of cancer cell glycosylation. Glycobiology 2009, 19, 899-909. Epub 2009 May 11.
36. Ueda, K., Katagiri, T., Shimada, T. et al., Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer. J Proteome Res. 2007, 6, 3475-3483. Epub 2007 Aug 18.
37. Tian, Y., Kelly-Spratt, K. S., Kemp, C. J., Zhang, H., Identification of glycoproteins from mouse skin tumors and plasma. Clin. Proteom. 2008, 4, 117-136.
38. Kaji, H., Isobe, T., Liquid chromatography/mass spectrometry (LC/MS)-based glycoproteomics technologies for cancer biomarker discovery. Clin. Proteom. 2008, 4, 14-24.
39. Zhang, H., Cotter, R. J., Glycoproteomics: new technology developments and applications provide renewed interest in glycoproteins. Clin. Ptoteom. 2008: 4, 1-4.
40. Zhang, H., Li, X. J., Martin, D. B., Aebersold, R., Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 2003, 21, 660-666.
41. Tian, Y., Zhou, Y., Elliott, S., Aebersold, R. et al., Solid phase extraction of N-linked glycopeptides. Nat. Protoc. 2007, 2, 334-339.
42. Sun, B., Ranish, J. A., Utleg, A. G., White, J. T., et al. Shotgun glycopeptide capture approach coupled with mass spectrometry for comprehensive glycoproteomics. Mol. Cell. Proteomics 2007, 6, 141-149.
43. Kaji, H., Saito, H., Yamauchi, Y., Shinkawa, T., et al., Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify N-linked glycoproteins. Nat. Biotechnol. 2003, 21, 667-672.
44. Zauner, G., Koeleman, C. A., Deelder, A. M., Wuhrer, M., Mass spectrometric O-glycan analysis after combined O-glycan release by beta-elimination and 1-phenyl-3-methyl-5-pyrazolone labeling. Biochim. Biophys. Acta 2011, DOI: org/10.1016/j.bbagen.2011.07.004.
45. Zheng, Y., Guo, Z., Cai, Z., Combination of beta-elimination and liquid chromatography/quadrupole time-of-flight mass spectrometry for the determination of O-glycosylation sites. Talanta 2009, 78, 358-363.
46. Madera, M., Mechref, Y., Klouckova, I., Novotny, M. V., Semiautomated high-sensitivity profiling of human blood serum glycoproteins through lectin preconcentration and multidimensional chromatography/tandem mass spectrometry. J. Proteome Res. 2006, 5, 2348-2363.
47. Chen, R., Jiang, X., Sun, D., Han, G. et al., Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J. Proteome Res. 2009, 8, 651-661.
48. Hirabayashi, J., Kuno, A., Tateno, H., Lectin-based structural glycomics: a practical approach to complex glycans. Electrophoresis 2011, 32, 1118-1128.
49. Kuno, A., Matsuda, A., Ikehara, Y., Narimatsu, H. et al., Differential glycan profiling by lectin microarray targeting tissue specimens. Methods Enzymol. 2010, 478, 165-179.
50. Cummings, R. D., Kornfeld, S., Fractionation of asparaginelinked oligosaccharides by serial lectin-agarose affinity chromatography. A rapid, sensitive, and specific technique. J. Biol. Chem. 1982, 257, 11235-11240.
51. Wiener, M. C., van Hoek, A. N., A lectin screening method for membrane glycoproteins: application to the human CHIP28 water channel (AQP-1). Anal. Biochem. 1996, 241, 267-268.
52. Bunkenborg, J., Pilch, B. J., Podtelejnikov, A. V., Wisniewski, J. R., Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. Proteomics 2004, 4, 454-465.
53. Yamamoto, K., Tsuji, T., Osawa, T., Analysis of asparaginelinked oligosaccharides by sequential lectin-affinity chromatography. Methods Mol. Biol. 1998, 76, 35-51.
54. Wang, Y., Wu, S. L., Hancock, W. S., Approaches to the study of N-linked glycoproteins in human plasma using lectin affinity chromatography and nano-HPLC coupled to electrospray linear ion trap-Fourier transform mass spectrometry. Glycobiology 2006, 16, 514-523.
55. Pan, S., Wang, Y., Quinn, J. F., Peskind, E. R. et al., Identification of glycoproteins in human cerebrospinal fluid with a complementary proteomic approach. J. Proteome Res. 2006, 5, 2769-2779.
56. Lee, A., Kolarich, D., Haynes, P. A., Jensen, P. H. et al., Rat liver membrane glycoproteome: enrichment by phase partitioning and glycoprotein capture. J. Proteome Res. 2009, 8, 770-781.
57. Sparbier, K., Wenzel, T., Kostrzewa, M., Exploring the binding profiles of ConA, boronic acid and WGA by MALDITOF/TOF MS and magnetic particles. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2006, 840, 29-36.
58. Xu, Y., Wu, Z., Zhang, L., Lu, H. et al. Highly specific enrichment of glycopeptides using boronic acid-functionalized mesoporous silica. Anal. Chem. 2009, 81, 503-508.
59. Hagglund, P., Bunkenborg, J., Elortza, F., Jensen, O. N. et al., A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation. J. Proteome Res. 2004, 3, 556-566.
60. Alvarez-Manilla, G., Atwood, J., Guo, Y., Warren, N. L. et al., Tools for glycoproteomic analysis: size exclusion chromatography facilitates identification of tryptic glycopeptides with N-linked glycosylation sites. J. Proteome Res. 2006, 5, 701-708.
61. Kobzik, L., Lung. in: Cotran, R. S., Kumer, V., Collins, T., (Eds.) Robbins Pathologic Basis of Disease, 7th ed. Saunders, Philadelphia 2004 pp.697-755.
62. Zhang, H., Chan, D. W., Cancer biomarker discovery in plasma using a tissue-targeted proteomic approach. Cancer Epidemiol. Biomarkers Prev. 2007, 16, 1915-1917.
63. Li, Y., Sokoll, L. J., Barker, P. E., Zhang, H. et al., Mass spectrometric identification of proteotypic peptides from clinically used tumor markers. Clin. Proteom. 2008, 4, 58-66.
64. Rho, J. H., Roehrl, M. H., Wang, J. Y., Tissue proteomics reveals differential and compartment-specific expression of the homologs transgelin and transgelin-2 in lung adenocarcinoma and its stroma. J Proteome Res. 2009, 8, 5610-5618.
65. Rho, J. H., Roehrl, M. H., Wang, J. Y., Glycoproteomic analysis of human lung adenocarcinomas using glycoarrays and tandem mass spectrometry: differential expression and glycosylation patterns of vimentin and fetuin A isoforms. Protein J. 2009, 28, 148-160.
66. Tian, Y., Gurley, K., Meany, D. L., Kemp, C. J., et al., N-linked glycoproteomic analysis of formalin-fixed and paraffin-embedded tissues. J. Proteome Res. 2009, 8, 1657-1662.
67. Magi, B., Bargagli, E., Bini, L., Rottoli, P., Proteome analysis of bronchoalveolar lavage in lung diseases. Proteomics 2006, 6, 6354-6369.
68. Rottoli, P., Bargagli, E., Landi, C., Magi, B., Proteomic analysis in interstitial lung diseases: a review. Curr. Opin. Pulm. Med. 2009, 15, 470-478.
69. Wattiez, R., Falmagne, P., Proteomics of BAL fluid. J Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2005, 815, 169-178.
70. Plymoth, A., Löfdahl, C. G., Ekberg-Jansson, A., Dahlbäck, M. et al., Human bronchoalveolar lavage: biofluid analysis with special emphasis on sample preparation. Proteomics 2003, 3, 962-972.
71. Tyan, Y. C., Wu, H. Y., Lai, W. W., Su, W. C. et al., Proteomic profiling of human pleural effusion using two-dimensional nano liquid chromatography tandem mass spectrometry. J. Proteom Res. 2005, 4, 1274-1286.
72. Soltermann, A., Ossola, R., Kilgus-Hawelski, S., von Eckardstein, et al., N-glycoprotein profiling of lung adenocarcinoma pleural effusions by shotgun proteomics. Cancer Cytopathol. 2008, 114, 124-133.
73. Chan, H. P., Lewis, C., Thomas, P. S., Exhaled breath analysis: novel approach for early detection of lung cancer. Lung Cancer 2009, 63, 164-168.
74. Dalaveris, E., Kerenidi, T., Katsabeki-Katsafli, A., Kiropoulos, T., et al., VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer. Lung Cancer 2009, 64, 219-225.
75. Tian, T., Hao, J., Xu, A., Luo, C. et al., Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis. Cancer Sci. 2007, 98, 1265-1274.
76. Xu, A., Hao, J., Zhang, Z., Tian, T. et al., 14-kDa phosphohistidine phosphatase and its role in human lung cancer cell migration and invasion. Lung Cancer 2010, 67, 48-56.
77. West, M. B., Hanigan, M. H., γ-glutamyl transpeptidase is a heavily N-glycosylated heterodimer in HepG2 cells. Arch. Biochem. Biophys. 2010, 504, 177-181.
78. Kelloff, G. J., Lippman, S. M., Dannenberg, A. J., Sigman, C. C. et al., AACR Task Force on Cancer Prevention. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cnacer-a plan to move forward. Clin. Cancer Res. 2006, 12, 3661-3697.
79. Boja, E., Hiltke, T., Rivers, R., Kinsinger, C., et al., Evolution of clinical proteomics and its role in medicine. J. Proteome Res. 2011, 10, 66-84.
80. Zeng, X., Hood, B. L., Sun, M., Conrads, T. P., et al., Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry. J. Proteome Res. 2010, 9, 6440-6449.
81. Hongsachart, P., Huang-Liu, R., Sinchaikul, S., Pan, F. M. et al., Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with ling adenocarcinoma. Electrophoresis 2009, 30, 1206-1220.
82. Ueda, K., Takami, S., Saichi, N., Daigo, Y. et al., Development of serum glycoproteomic profiling technique; simultaneous identification of glycosylation sites and site-specific quantification of glycan structure changes. Mol. Cell. Proteomics 2010, 9, 1819-1828.
83. Ueda, K., Fukase, Y., Katagiri, T., Ishikawa, N. et al., Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays. Proteomics 2009, 9, 2182-2192.
84. Tsai, H. Y., Boonyapranai, K., Sriyam, S., Yu, C. J. et al., Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer. Proteomics 2011, 11, 2162-2170.
85. Lee, R. T., Lee, Y. C., Affinity enhancement by multivalent lectin-carbohydrate interaction. Glycoconj. J. 2000, 17, 543-551.
86. Lajoie, P., Partrideg, E. A., Guay, G., Goetz, J. G., et al., Plasma membrane domain organization regulates EGFR signaling in tumor cells. J. Cell Biol. 2007, 179, 341-356.
87. Fernandes, H., Cohen, S., Bishayee, S., Glycosylation-induced conformational modification positively regulates receptor-receptor association: a study with an aberrant epidermal growth factor receptor (EGFRvIII/deltaEGFR) expressed in cancer cells. J. Biol. Chem. 2001, 276, 5375-5383.
88. Lau, K., Partridge, E. A., Silvescu, C. I., Grigorian, A. et al., Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 2007, 129, 123-124.
89. Liu, Y. C., Yen, H. Y., Chen, C. Y., Chen, C. H. et al., Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells. Proc. Natl. Acad. Sci. USA 2011, 108, 11332-11337. Epub 2011 Jun 27.
90. Venmans, B. J., van Boxem, T. J., Smith, E. F., Postmus, P. E. et al., Outcome of bronchial carcinoma in situ. Chest 2000, 117, 1572-1576.